Decrements in health‐related quality of life associated with adverse events in people with diabetes

Autor: Keng, MJ, Leal, J, Bowman, L, Armitage, J, Mihaylova, B

Publikováno v: Diabetes, Obesity and Metabolism. 24:530-538

Aim People with diabetes are at elevated risk of adverse events due to the disease and treatments. We estimate the decrements in health-related quality of life (QoL) associated with a range of adverse events. This will inform assessments of the effec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb32dd25b0f5d85694e09e8d6b5347b6
https://doi.org/10.1111/dom.14610

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort

Autor: Keng, MJ, Leal, J, Mafham, M, Bowman, L, Armitage, J, Mihaylova, B

Objectives: The UKPDS Outcomes Model developed using 30-year (1977-2007) data from the UKPDS is widely used for health outcomes’ projections and economic evaluations of therapies for patients with type 2 diabetes (T2D). However, its reliability for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::319dbd6168b0d833f13b3eea9b876527
https://ora.ox.ac.uk/objects/uuid:1a27d0da-8bda-4b4a-bb27-a193b574c07a

Racial/ethnic differences in FIM scores and length of stay for underinsured patients undergoing stroke inpatient rehabilitation.

Autor: Chiou-Tan FY, Keng MJ Jr., Graves DE, Chan K, Rintala DH

Publikováno v: American Journal of Physical Medicine & Rehabilitation; May2006, Vol. 85 Issue 5, p415-423, 9p

Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge.

Autor: Altunkaya J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK. Electronic address: james.altunkaya@ndph.ox.ac.uk., Li X; Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Adler A; Diabetes Trial Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, England, UK., Feenstra T; Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Fridhammar A; The Swedish Institute for Health Economics, Lund, Sweden., Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK., Lamotte M; IQVIA, Zaventem, Belgium; Th(is)(2)Modeling, Asse, Belgium., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, Wales, UK., Nilsson A; IQVIA, Zaventem, Belgium., Palmer AJ; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania, Australia., Quan J; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong., Smolen H; Medical Decision Modeling Inc, Indianapolis, IN, USA., Tran-Duy A; Centre for Health Policy, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, VIC, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia., Valentine W; Ossian Health Economics and Communications, Basel, Switzerland., Willis M; The Swedish Institute for Health Economics, Lund, Sweden., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK., Clarke P; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, England, UK.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Oct; Vol. 27 (10), pp. 1338-1347. Date of Electronic Publication: 2024 Jul 08.

Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.

Autor: Lui JNM; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Williams C; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Keng MJ; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Hopewell JC; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Sammons E; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Chen F; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Gray A; Health Economics Research Centre, Nuffield Department of Population Health University of Oxford Oxford United Kingdom., Bowman L; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom.; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health University of Oxford United Kingdom., Landray SMJ; Clinical Trial Service Unit and Epidemiological Studies Unit Nuffield Department of Population Health University of Oxford United Kingdom., Mihaylova B; Health Economics and Policy Research Unit, Wolfson Institute of Population Health Queen Mary University of London United Kingdom.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2023 Oct 03; Vol. 12 (19), pp. e030766. Date of Electronic Publication: 2023 Sep 26.